Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition comprising a gene vector that selectively depletes P16 positive senescent cells

Composition comprising a gene vector that selectively depletes P16 positive senescent cells

US Patent 10550378 · Granted Feb 4, 2020

Estimated economic value: $4,287,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL s2025
Treating liver disease by selectively eliminating senescent cells2024
Treating cardiovascular disease by selectively eliminating senescent cells2024
Methods of inhibiting pathological angiogenesis2024
Treating cognitive decline and other neurodegenerative conditions by selectively2022
Synthetic bile acid compositions and methods2021
Methods of inhibiting pathological angiogenesis2021
Synthetic bile acid compositions and methods2021
Technology to inhibit vascular changes that lead to vision loss in the eye2020
Removing senescent cells from a mixed cell population or tissue using a phosphoi2019
Compositions of matter for treatment of ophthalmic conditions by selectively rem2019
Unit dose of an aryl sulfonamide that is effective for treating eye disease and 2019